课题基金 / 基金详情

The treatment of liver cirrhosis by transplantation of the hepatic progenitor cells with transformation

The treatment of liver cirrhosis by transplantation of the hepatic progenitor cells with transformation
转化肝祖细胞移植治疗肝硬化
批准号:
23591987
负责人:
MIZUMOTO MASAKI
金额:
$3.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One of the purpose of this study was to evaluate the effectiveness of BMP7. BMP7 is an inhibitor of TGF-beta which is one of the key moleclue of liver cirrhosis. We made BMP7 expressing plasmid vector, and perfomed transfection using a model of liver cirrhosis induced by CCl4.Howerver, the findings of the liver cirrhosis showed by HE staining, Masson Trichrome staining (MT staining), and RT-PCR for collagen 1a gene expression were not different between the group with BMP7 tarnsfection and without BMP7 transfection in the mouse liver cirrhosis model. With these results, we could not show the effectiveness of BMP7 in the treatment of liver cirrhosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
新型全氟醚羧酸通过端粒缩短激活TGF-β/Smad 通路致儿童肾功能损伤的机制研究
表观遗传调节因子BRD4调控TGF-β1相关纤维化基因和炎症因子参与腹膜透析相关性腹膜纤维化
LOX通过激活TGF-β/SMAD通路介导糖尿病足溃疡难愈及复发的机制研究
  • 批准号:
    2026JJ82108
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谭亮
  • 依托单位:
基于上皮-间充质可塑性特征构建胶质瘤预后模型及靶向特定蛋白PTGFRN促进TGF-β/Smad3信号的机制研究